Literature DB >> 24053039

Converging evidence for gamma synchrony deficits in schizophrenia.

B J Roach1, J M Ford, R E Hoffman, D H Mathalon.   

Abstract

BACKGROUND: In electroencephalogram (EEG) studies of auditory steady-state responses (ASSRs), patients with schizophrenia show a deficit in power and/or phase-locking, particularly at the 40 Hz frequency where these responses resonate. In addition, studies of the transient gamma-band response (GBR) elicited by single tones have revealed deficits in gamma power and phase-locking in schizophrenia. We examined the degree to which the 40 Hz ASSR and the transient GBR to single tones are correlated and whether they assess overlapping or distinct gamma-band abnormalities in schizophrenia.
METHODS: EEG was recorded during 40 Hz ASSR and auditory oddball paradigms from 28 patients with schizophrenia or schizoaffective disorder (SZ) and 25 age- and gender-matched healthy controls (HC). The ASSR was elicited by 500 ms click trains, and the transient GBR was elicited by the standard tones from the oddball paradigm. Gamma phase and magnitude values, calculated using Morlet wavelet transformations, were used to derive total power and phase-locking measures.
RESULTS: Relative to HC, SZ patients had significant deficits in total gamma power and phase-locking for both ASSR- and GBR-based measures. Within both groups, the 40 Hz ASSR and GBR phase-locking measures were significantly correlated, with a similar trend evident for the total power measures. Moreover, co-varying for GBR substantially reduced 40 Hz ASSR power and phase-locking differences between the groups.
CONCLUSIONS: 40 Hz ASSR and transient GBR measures provide very similar information about auditory gamma abnormalities in schizophrenia, despite the overall enhancement of 40 Hz ASSR total power and phase-locking values relative to the corresponding GBR values.

Entities:  

Mesh:

Year:  2013        PMID: 24053039      PMCID: PMC4165558          DOI: 10.1016/b978-0-7020-5307-8.00011-9

Source DB:  PubMed          Journal:  Suppl Clin Neurophysiol        ISSN: 1567-424X


  70 in total

1.  Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.

Authors:  Gregory A Light; Jung Lung Hsu; Ming H Hsieh; Katrin Meyer-Gomes; Joyce Sprock; Neal R Swerdlow; David L Braff
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

2.  Schizoaffective disorder - a possible MEG auditory evoked field biomarker.

Authors:  Martin Reite; Peter Teale; Dan Collins; Donald C Rojas
Journal:  Psychiatry Res       Date:  2010-05-21       Impact factor: 3.222

3.  Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.

Authors:  Mei-Hua Hall; Grantley Taylor; Dean F Salisbury; Deborah L Levy
Journal:  Schizophr Bull       Date:  2010-04-02       Impact factor: 9.306

4.  Forty-hertz midlatency auditory evoked potential activity predicts wakeful response during desflurane and propofol anesthesia in volunteers.

Authors:  R C Dutton; W D Smith; I J Rampil; B S Chortkoff; E I Eger
Journal:  Anesthesiology       Date:  1999-11       Impact factor: 7.892

5.  Alterations of the early auditory evoked gamma-band response in first-degree relatives of patients with schizophrenia: hints to a new intermediate phenotype.

Authors:  Gregor Leicht; Susanne Karch; Evangelos Karamatskos; Ina Giegling; Hans-Jürgen Möller; Ulrich Hegerl; Oliver Pogarell; Dan Rujescu; Christoph Mulert
Journal:  J Psychiatr Res       Date:  2010-11-09       Impact factor: 4.791

6.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

Review 7.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

8.  Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.

Authors:  David A Lewis; Raymond Y Cho; Cameron S Carter; Kevin Eklund; Sarah Forster; Mary Ann Kelly; Debra Montrose
Journal:  Am J Psychiatry       Date:  2008-10-15       Impact factor: 18.112

9.  Cortical source estimates of gamma band amplitude and phase are different in schizophrenia.

Authors:  Peter Teale; Dan Collins; Keeran Maharajh; Donald C Rojas; Eugene Kronberg; Martin Reite
Journal:  Neuroimage       Date:  2008-06-25       Impact factor: 6.556

10.  Neural mechanisms of intermodal sustained selective attention with concurrently presented auditory and visual stimuli.

Authors:  Katja Saupe; Erich Schröger; Søren K Andersen; Matthias M Müller
Journal:  Front Hum Neurosci       Date:  2009-11-30       Impact factor: 3.169

View more
  14 in total

1.  Early auditory gamma-band responses in patients at clinical high risk for schizophrenia.

Authors:  Veronica B Perez; Brian J Roach; Scott W Woods; Vinod H Srihari; Thomas H McGlashan; Judith M Ford; Daniel H Mathalon
Journal:  Suppl Clin Neurophysiol       Date:  2013

2.  Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report.

Authors:  Mei-Hua Hall; Chia-Yen Chen; Bruce M Cohen; Kevin M Spencer; Deborah L Levy; Dost Öngür; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-03-04       Impact factor: 3.568

3.  Auditory steady state response deficits are associated with symptom severity and poor functioning in patients with psychotic disorder.

Authors:  Tian-Hang Zhou; Nora E Mueller; Kevin M Spencer; Sonal G Mallya; Kathryn Eve Lewandowski; Lesley A Norris; Deborah L Levy; Bruce M Cohen; Dost Öngür; Mei-Hua Hall
Journal:  Schizophr Res       Date:  2018-05-26       Impact factor: 4.939

4.  Differences of temporal dynamics and signal complexity of gamma band oscillations in first-episode psychosis during a working memory task.

Authors:  Pascal Missonnier; Logos Curtis; Joseph Ventura; François R Herrmann; Marco C G Merlo
Journal:  J Neural Transm (Vienna)       Date:  2017-05-02       Impact factor: 3.575

5.  Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.

Authors:  Jose Cortes-Briones; Patrick D Skosnik; Daniel Mathalon; John Cahill; Brian Pittman; Ashley Williams; R Andrew Sewell; Mohini Ranganathan; Brian Roach; Judith Ford; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

6.  MEG and EEG demonstrate similar test-retest reliability of the 40Hz auditory steady-state response.

Authors:  Kristina T Legget; Allison K Hild; Sarah E Steinmetz; Steven T Simon; Donald C Rojas
Journal:  Int J Psychophysiol       Date:  2017-02-01       Impact factor: 2.997

7.  40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors.

Authors:  Digavalli V Sivarao; Ping Chen; Arun Senapati; Yili Yang; Alda Fernandes; Yulia Benitex; Valerie Whiterock; Yu-Wen Li; Michael K Ahlijanian
Journal:  Neuropsychopharmacology       Date:  2016-02-03       Impact factor: 7.853

8.  40-Hz auditory stimulation for intracranial interictal activity: A pilot study.

Authors:  Robert J Quon; Grace A Leslie; Edward J Camp; Stephen Meisenhelter; Sarah A Steimel; Yinchen Song; Alan B Ettinger; Krzysztof A Bujarski; Michael A Casey; Barbara C Jobst
Journal:  Acta Neurol Scand       Date:  2021-04-24       Impact factor: 3.915

9.  Phencyclidine Disrupts the Auditory Steady State Response in Rats.

Authors:  Emma Leishman; Brian F O'Donnell; James B Millward; Jenifer L Vohs; Olga Rass; Giri P Krishnan; Amanda R Bolbecker; Sandra L Morzorati
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.

Authors:  Frank H Duffy; Eugene D'Angelo; Alexander Rotenberg; Joseph Gonzalez-Heydrich
Journal:  BMC Med       Date:  2015-11-02       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.